Eric Bjerkholt is CHIEF FINANCIAL OFFICER of Mirum Pharmaceuticals, Inc.. Currently has a direct ownership of 14,470 shares of MIRM, which is worth approximately $490,243. The most recent transaction as insider was on May 10, 2024, when has been sold 470 shares (Common Stock) at a price of $21.05 per share, resulting in proceeds of $9,893. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.5K
3.36% 3M change
n/a 12M change
Total Value Held $490,243

ERIC BJERKHOLT Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 10 2024
BUY
Grant, award, or other acquisition
$9,893 $21.05 p/Share
470 Added 3.15%
14,470 Common Stock
Mar 27 2024
BUY
Open market or private purchase
$49,600 $24.8 p/Share
2,000 Added 12.5%
14,000 Common Stock
Mar 18 2024
BUY
Open market or private purchase
$51,600 $25.8 p/Share
2,000 Added 14.29%
12,000 Common Stock
Sep 11 2023
BUY
Open market or private purchase
$296,500 $29.65 p/Share
10,000 Added 50.0%
10,000 Common Stock

Also insider at

KDNY
CHINOOK THERAPEUTICS, INC. Healthcare
CERS
CERUS CORP Healthcare
SRZN
Surrozen, Inc. Healthcare
GRAY
GRAYBUG VISION, INC. Healthcare
EB

Eric Bjerkholt

CHIEF FINANCIAL OFFICER
Seattle, WA

Track Institutional and Insider Activities on MIRM

Follow Mirum Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MIRM shares.

Notify only if

Insider Trading

Get notified when an Mirum Pharmaceuticals, Inc. insider buys or sells MIRM shares.

Notify only if

News

Receive news related to Mirum Pharmaceuticals, Inc.

Track Activities on MIRM